Close Menu

Elitech

The PCR test detects SARS-CoV-2, influenza A/B, and respiratory syncytial virus type A and B and runs on the Elite InGenius platform and other major thermcyclers.

The firm was one of the first to have a COVID-19 test receive EUA from the FDA. It is also developing a COVID-19/flu combo test for which it will seek EUA.

The kit is designed to detect the RdRP gene, E gene, and N gene of the virus and runs on all major thermocyclers.

The Elite InGenius has the sample prep capabilities typical of high-throughput platforms, yet it can run more samples than smaller instruments.

The fully automated system has 12 independent thermal cyclers and runs the firm's diagnostic kits, but it can also operate as an open instrument.

NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.

Canon has been awarded US Patent No. 8,466,272, "Probe set and method for identifying HLA allele."
Mamoru Tsukada has been named as inventor on the patent.

GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.

The vote of confidence is a stepping stone for the company to seek 510(k) approval for an H1N1 test on its platform; to tackle the point-of-care diagnostic market; and to further develop tests for other infectious diseases.

While the amount of the funding was not disclosed, an official from the investment firm that founded Mirina said that it is sufficient to fund the company's operations for 12 to 15 months.

Pages

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner. 

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.